title: Adaptive Randomization of Neratinib in Early Breast Cancer.
authors: International Drug Development Institute, Louvain-la-Neuve, Belgium marc.buyse@iddi.com.
authors: Marc
authors: M
authors: Buyse
authors: International Drug Development Institute, Louvain-la-Neuve, Belgium marc.buyse@iddi.com.
authors: Everardo D
authors: ED
authors: Saad
authors: International Drug Development Institute, Louvain-la-Neuve, Belgium marc.buyse@iddi.com.
authors: Tomasz
authors: T
authors: Burzykowski
mesh_terms: D001943:Breast Neoplasms / Q000188:drug therapy*; D006801:Humans; D011804:Quinolines / Q000627:therapeutic use; D011897:Random Allocation; D018719:Erb-b2 Receptor Tyrosine Kinases
chemical_list: D011804:Quinolines; D018719:Erb-b2 Receptor Tyrosine Kinases